Evolution of peritoneal dialysis in France since 2018 and during the «COVID years. RDPLF data report

Authors

DOI:

https://doi.org/10.25796/bdd.v5i3.67903

Keywords:

Peritoneal dialysis, transfers, COVID-19, prevalence, incidence, home dialysis, transplantation

Abstract

Almost all (99%) of the patients treated by peritoneal dialysis in France are registered in the RDPLF database. Apart from any statistical analysis aimed at interpreting the figures, this work is a report of the raw data observed in the population of Stage V renal failure patients treated by peritoneal dialysis since the beginning of the Covid epidemic and in the two years preceding it. Since the beginning of the epidemic, these data seem to show a decrease in the incidence of peritoneal dialysis treatment and an increase in transfers to center-based hemodialysis. In addition, there has been a decrease in the number of registrations on the transplant waiting list and a decrease in the number of transplants. While the temporary decrease in transplantation activity may be explained by the disorganization caused by the epidemic in the hospitals, a decrease in the number of indications for home dialysis probably merits further reflection on its causes, especially since this result is in contrast with trends in other countries. This report is intended to encourage more precise studies on the value of home dialysis during the epidemic.

INTRODUCTION

The occurrence of the SARS-Cov2 epidemic has had dramatic consequences on the morbidity and mortality of patients with stage-V chronic kidney disease or transplanted patients. In France, the evolution of the rate of contamination and lethality is communicated weekly by the Agence de Biomédecine and the REIN registry[1]. While many teams around the world have recommended prioritizing home dialysis and particularly peritoneal dialysis (PD)[2];[3];[4], we thought it was important to investigate the situation in France.

We report the evolution of PD in France since 2018. This is raw data extracted from the RDPLF database, specifically from its main module that represents 99% of patients treated with PD in France. We present this information in the form of tables and graphs, without interpretation, with our aim being to provide the reader with immediately accessible general information that can be used as a support for oral presentations and as a basis for reflection for future work. All tables and figures may be freely used provided that their origin is cited (reference of this article or at least its DOI).

I - PROFILE OF PATIENTS TREATED WITH PERITONEAL DIALYSIS IN MAINLAND FRANCE IN 2021

Prevalent patients in the year(Table IandFigure 1)

Sexe ratio : women : 36,4 % Men : 63,6 %

All patientsCAPDAPD
Numbers411025681542
Age66,2±16,270,6±14,258,9±16,8
Table I.Total number of patients treated at least one day during the year

Figure 1.Age distribution of PD patients treated in 2021

Diabetes status

44.8% of patients treated with peritoneal dialysis in metropolitan France in 2021 had diabetes. The distribution of patients according to diabetic status and treatment of their diabetes is summarized inTable II.

Among diabetic patients on insulin, 98.7% were on subcutaneous insulin and 1.34% on intraperitoneal insulin.

Diabetic statusPercentages
Non-diabetics65,28%
Diabetics treated with diet4,21%
Orally treated diabetics6,89%
Diabetics on subcutaneous insulin23,31%
Diabetics on intraperitoneal insulin0,32%
Table II.Distribution of diabetic status among patients treated with PD in 2021

Autonomy and PD type (CAPD vs APD)

In 2021, 43.7% of patients required assistance to perform their peritoneal dialysis; this assistance is mostly provided by private nurses at home, paid by national health insurance (Table III).

AutonomyNumbersPercentages
Autonomous23140.56302
Nurse assisted15600.37956
Family assisted2130.05182
Assisted (unspecified)210.00511
Missing data20.00049
Table III.Breakdown of patients by level of autonomy
CAPDAPD
Number/%1748 (61%)1095 (49%)
Age70.7±13,560.5±15,1
Sex ratio (F/M)38.4%/61.6%33.6%/66.7%
Diabetics40.6%24.7%
Autonomous45.1%81.9%
Nurse assisted50.3%13.35%
Family assisted4.6%4.75%
Table IV.Profile of PD patient;s according to type of treatment

CAPD patients are older than those on APD, more often diabetic and 50% require nurse assistance, contrary to APD where the majority (nearly 82%) are autonomous (Table IV).

Partition of PD techniques at 31 December 2021

On December 31, 2021, 2724 patients were treated by PD in metropolitan France, 1714 (63%) in CAPD and 1010 (37%) in APD.

In CAPD, the age was 70.6 years±13.6, the sex ratio was 38% female and 61.7% male. In APD the age was 60 years±16.2 and the sex ratio was 33.6% women and 66.4% men.

Figure 2shows the distribution of the PD technique used according to age.

Figure 2.Age distribution of patients treated with CAPD or APD, on December 2021. Percentages in a technique, CAPD or APD, are calculated in relation to the total number in the technique.

Peritoneal infections in 2021

The latest ISPD guidelines recommend that peritonitis recidives should not be counted in the calculation of the peritonitis rate; nevertheless, clinical recurrences are indeed additional stresses for patients and their peritoneal membrane, so we report the results with and without counting recurrences. All calculations were computed using the method recommended by ISPD[5].

- Rate of peritoneal infection (including recidives): 1 episode every 37.8 months or 0.32 episodes per year

- Rate of peritoneal infection (excluding recidives): 1 episode every 40 months or 0.30 episodes per year

TheTable Vsummarizes the distribution of organisms cultured in 2021. Multiple germ peritonitis is not detailed but is the subject of an accepted work in the journal Nephrology Dialysis and Transplantation (in press)[6].

The percentage of aseptic peritonitis was 15.1%, in line with international recommendations. However, it should be remembered that the rate of culture-negative peritonitis may vary considerably between centers, as we have previously shown[7].

GermsNumbersPercentages
Gram Plus cocci38744,7%
Gram negative Bacilli23126,7%
Gram plus bacilli394,5%
Negative cultures13115,1%
Multiple germs627,2%
Yeasts101,2%
Gram less cocci50,6%
Various10,1%
Table V.Distribution of organisms identified in peritonitis occurring in 2021.

Waiting times for 2021 transplanted patients (Table VI)

Duration of treatment before transplantNumbersPercentages
0-1 years2713,2%
1-2 years7335,6%
2-3 years4722,9%
3-4 years2411,7%
4-5 years146,8%
5 years and more209,8%
Table VI.205 patients treated by peritoneal dialysis were transplanted during the year. Their duration of treatment before transplantation varied from less than 1 year to more than 5 years. Slightly less than 50% were transplanted before 2 years of treatment. The percentages are calculated in relation to the total number of transplant
.....

References

- Situation de l’épidémie de COVID-19 chez les patients dialysés et greffés rénaux en France au 29 août 2022. BULLETIN N°106[Internet].

Available at https://www.agence-biomedecine.fr/IMG/pdf/bulletin_no106.pdf

- Cozzolino M, Conte F, Zappulo F, Ciceri P, Galassi A, Capelli I, Magnoni G, La Manna G. COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis? Clin Kidney J. 2021 Feb 2;14(Suppl 1):i6-i13. doi: 10.1093/ckj/sfab023. DOI: https://doi.org/10.1093/ckj/sfab023

- Rostoker G, Issad B, Fessi H, Massy ZA. Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective. J Nephrol. 2021 Aug;34(4):985-989. doi: 10.1007/s40620-021-01061-7. DOI: https://doi.org/10.1007/s40620-021-01061-7

- Canney M, Er L, Antonsen J, Copland M, Singh RS, Levin A. Maintaining the Uptake of Peritoneal Dialysis During the COVID-19 Pandemic: A Research Letter. Can J Kidney Health Dis. 2021 Feb 15;8:2054358120986265. doi: 10.1177/2054358120986265. DOI: https://doi.org/10.1177/2054358120986265

- Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, Mehrotra R, Okpechi IG, Perl J, Piraino B, Runnegar N, Teitelbaum I, Wong JK, Yu X, Johnson DW. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022 Mar;42(2):110-153. DOI: https://doi.org/10.1177/08968608221080586

- Valentine Forté, Sophie Novelli, Mohamad Zaidan, Renaud Snanoudj, Christian Verger, Séverine Beaudreuil. Microbiology and outcomes of polymicrobial peritonitis associated with peritoneal dialysis: a register-based cohort study from the French Language Peritoneal Dialysis Registry (RDPLF). NDT (accepted september 2022)

- Verger C, Veniez G, Dratwa M. Variability of aseptic peritonitis rates in the RDPLF. Bull Dial Domic [Internet]. 2018 Jun. 13 [cited 2022 Sep. 5];1(1):9-13. Available from: https://doi.org/10.25796/bdd.v1i1.30 DOI: https://doi.org/10.25796/bdd.v1i1.30

- Lucas Pierre-michel J, Collart F, Baudoux T, Bonvoisin C, De Smet J-M, Devresse A, Mbaba Mena J, Radermacher L, des Grottes J-M. Has COVID-19 reduced the management of end-stage kidney disease in 2020? . Bull Dial Domic [Internet]. 2021 Apr. 7 [cited 2022 Sep. 5];4(1):53-4.

Available from: https://doi.org/10.25796/bdd.v4i1.61453 DOI: https://doi.org/10.25796/bdd.v4i1.61453

- Rivara MB, Mehrotra R. The changing landscape of home dialysis in the United States. Curr Opin Nephrol Hypertens. 2014 Nov;23(6):586-91. doi: 10.1097/MNH.0000000000000066. DOI: https://doi.org/10.1097/MNH.0000000000000066

Submitted

2022-09-03

Published

2022-09-06

How to Cite

1.
Verger C, Fabre E. Evolution of peritoneal dialysis in France since 2018 and during the «COVID years. RDPLF data report. Bull Dial Domic [Internet]. 2022 Sep. 6 [cited 2025 Nov. 1];5(3):193-201. Available from: https://bdd.rdplf.org/index.php/bdd/article/view/67903